Archives

November 11, 2026

Treasury Proposes to Include Biotechnology as Prohibited Technology under COINS Act

On October 26, 2026, the U.S. Department of the Treasury’s (Treasury) Office of Investment Security published a proposed rule setting forth regulations that would implement Subtitle C of the Comprehensive Outbound Investment National Security (COINS) Act, which is codified at Title VIII of the Defense Production Act. 91 Fed. Reg. 67396. The proposed rule would require U.S. persons to notify Treasury regarding certain transactions involving foreign persons that are engaged in...
October 21, 2026

Bipartisan, Bicameral Bills Would Designate Biotechnology and Biomanufacturing as Critical Infrastructure

On September 24, 2026, the National Security Commission on Emerging Biotechnology (NSCEB) announced the introduction of two bills “that would require the Cybersecurity and Infrastructure Security Agency (CISA) to protect biotechnology data and infrastructure from malicious actors.” Senators Todd Young (R-IN), NSCEB Chair, and Maggie Hassan (D-NH) introduced the bills in the Senate, and Representatives and NSCEB Commissioners Stephanie Bice (R-OK) and Ro Khanna (D-CA), as well as...
September 16, 2026

House Bill Seeks Information on Federal Biotechnology Research and Security

On September 9, 2026, Representatives Brian Babin (R-TX), Chair of the House Science, Space, and Technology Committee, and Rich McCormick (R-GA), Chair of the Investigations and Oversight Subcommittee, sent letters to U.S. Department of Energy (DOE) Secretary Chris Wright, National Institutes of Health (NIH) Director Jay Bhattacharya, and National Science Foundation (NSF) Acting Director Brian Stone requesting information on how those agencies are “advancing U.S. leadership in biotechnology...
August 26, 2026

Bipartisan Senate Bill Would Prevent “Offshoring Biotech Industry to Communist China”

On August 6, 2026, Senators Pete Ricketts (R-NE) and Elissa Slotkin (D-MI) introduced the Biotech Investment National Security Act (BINSA) (S. 5316). According to Ricketts’s August 6, 2026, press release, the bill would ensure American investment in “adversary biotechnology” is subject to the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act. Enacted in December 2025, the COINS Act directs the Secretary of the Treasury to issue regulations...
August 3, 2026

Senate Subcommittee Will Hold Hearing on Building a Resilient Health Care Future with Biotechnology

On August 4, 2026, the Senate Finance Subcommittee on Health Care will hold a hearing on “Building a Resilient Health Care Future with Biotechnology.” The Subcommittee will hear from the following witnesses: Alan D. Palkowitz, Ph.D., President and Chief Executive Officer (CEO), Indiana Biosciences Research Institute (IBRI); Michelle Rozo, Ph.D., Vice Chair, National Security Commission on Emerging Biotechnology (NSCEB); Vera P. Luther, M.D., MS, Section Chief of Infectious Disease and...
August 3, 2026

USDA’s 2026 Unified Agenda Includes Biobased Product and Biotechnology Rulemakings

In July, the Office of Management and Budget (OMB) published the Trump Administration’s 2026 Unified Agenda. The U.S. Department of Agriculture’s (USDA) Unified Agenda includes the following rulemakings regarding biobased products and biotechnology: Technical Guidelines for the Production of Regenerative Agricultural Biofuel Feedstocks: The Biden USDA issued an interim final rule (IFR) to establish new regulations that will set requirements for the quantification, reporting, and verification...
July 21, 2026

House Bill Would Establish Dedicated Biotechnology Official in State Department

On July 16, 2026, Representative Rich McCormick (R-GA) introduced the Biotechnology Diplomacy Leadership Act (H.R. 9755). According to McCormick’s July 16, 2026, press release, the bill would “strengthen America’s global leadership in biotechnology by establishing a dedicated biotechnology lead” in the U.S. Department of State (State Department). The press release states that as biotechnology emerges as a “critical arena of global competition,” the United States faces pressure to...
July 7, 2026

OECD Publishes Policy Paper on Anticipatory Governance for Responsible Innovation in Synthetic Biology

In May 2026, the Organisation for Economic Co-operation and Development (OECD) published a policy paper entitled Anticipatory Governance for Responsible Innovation in Synthetic Biology. The policy paper examines how OECD member countries are adapting governance frameworks to support responsible innovation in synthetic biology. Using the OECD Framework for Anticipatory Governance of Emerging Technologies as an analytical lens, it reviews national strategies, policy instruments, and governance...
June 29, 2026

Council of the EU Agrees on Mandate on Measures to Advance Biotechnology Innovation in the EU

The Council of the European Union (EU) announced on June 16, 2026, that it has agreed on its position on targeted amendments to health legislation that seek to boost innovation in the EU’s biotechnology sector. The European Commission (EC) drafted a directive that would amend two existing directives to streamline the rules on placing certain genetically modified microorganisms (GMM) on the market and to update the rules on organ processing to reflect certain scientific advances. The proposed...
June 2, 2026

Bipartisan Bill Intends to Advance U.S. Leadership in Biotechnology

On May 21, 2026, Representatives April McClain Delaney (D-MD) and Jay Obernolte (R-CA) introduced the Standards and Calibration for American Leadership in Engineering Biology (SCALE Biology) Act (H.R. 8981). According to McClain Delaney’s May 22, 2026, press release, the bipartisan legislation would establish a new federal program dedicated to biometrology, “an advanced science critical to U.S. leadership in emerging biotechnology, including healthcare innovation, agricultural research,...